Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02928107 · ClinicalTrials.gov registry record · NA
Addressing Barriers to Adult Hearing Healthcare
A NA study of Hearing Loss and Geriatric Disorder, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 1,146
- Enrollment target
- 6
- Study locations
NCT02928107: Completed NA study of Hearing Loss and Geriatric Disorder, sponsored by Duke University.
NCT02928107 is a NA study of Hearing Loss and Geriatric Disorder that has completed, run by Duke University. The registered enrollment target is 1,146 participants, below the 6,101-participant average among 58 other Hearing Loss trials with a reported enrollment target (81% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02928107, a NA study of Hearing Loss and Geriatric Disorder, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,146 participants
- Enrollment target
- 6
- Study locations
Study Summary
The aim of this project is to develop evidence that can inform hearing health care best practices for adults between the ages of 65-75, and determine what level of involvement by the primary care practitioner (PCP) is required to inform and encourage adults age 65-75 to follow through with routine hearing screening. This study also aims to evaluate the accuracy of assessment of medical conditions for which the FDA requires physician evaluation and management prior to hearing aid fitting, and determine which medical conditions should require medical evaluation prior to hearing aid fitting. The results of this study should provide information to implement changes in health care policy to facilitate accessible and affordable hearing health care.
Primary Outcome
The proportion (%) of subjects in Groups 1 and 2 who take the test will be compared to those in Group 3.
Conditions Studied
Interventions
- OTHER Tele-HS
- OTHER PCP encouragement
Study Locations (6)
New York
- Northwell Health - New Hyde Park
- New York Eye and Ear of Mount Sinai - New York
Michigan
- University of Michigan - Ann Arbor
North Carolina
- Duke University Medical Center - Durham
Oregon
- Central Oregon ENT - Bend
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,146 participants |
| Start Date | 2016-10-31 |
| Est. Completion | 2021-08-27 |
| Phase | NA |
What the finished NCT02928107 record still lists
NCT02928107 is an interventional study that assigns participants to a tested intervention. Its 1,146 participants enrollment target places it among the larger protocols in the corpus, below the 6,101-participant average among 58 other Hearing Loss trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Tele-HS is the first listed.
NCT02928107 lists 6 locations in 5 states (New York, Michigan, North Carolina).
Frequently Asked Questions
What is clinical trial NCT02928107 about?
NCT02928107 is a clinical study titled "Addressing Barriers to Adult Hearing Healthcare". The aim of this project is to develop evidence that can inform hearing health care best practices for adults between the ages of 65-75, and determine what level of involvement by the primary care practitioner (PCP) is required to inform and encourage adults age 65-75 to follow through with routine h...
What is the current status of trial NCT02928107?
This trial is currently completed. It is a NA study. The enrollment target is 1,146 participants. The study started on 2016-10-31. Estimated completion is 2021-08-27.
What conditions does trial NCT02928107 study?
This clinical trial studies the following conditions: Hearing Loss, Geriatric Disorder.
What interventions are being tested in trial NCT02928107?
The interventions under investigation include: Tele-HS (OTHER), PCP encouragement (OTHER).
Who is sponsoring clinical trial NCT02928107?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02928107 being conducted?
This trial has 6 study locations across Michigan, New York, North Carolina, Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02928107's enrollment target sits among peer trials
1,146 6th of 58 higher than 53 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06676319 · 1,147 participants · Phase 2
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
- NCT06129864 · 1,145 participants · Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- NCT06408181 · 1,150 participants · Phase 3
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
- NCT06528314 · 1,150 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI